These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3137131)

  • 1. Immune status in thalassemia major.
    Ballart IJ; Estevez ME; Muchinik G; Sen L
    Haematologica; 1988; 73(2):153. PubMed ID: 3137131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological pattern of homozygous beta-thalassemia after splenectomy].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1983; 91(1):39-44. PubMed ID: 6604258
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologic reactivity in thalassemia.
    Boonpucknavig S; Chiewsilp P; Isarangkura P; O'Charoen R; Akkawat R
    Birth Defects Orig Artic Ser; 1987; 23(5A):565-9. PubMed ID: 3500746
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility to infections in beta-thalassemia major.
    Schilirò G; Romeo MA; Russo A; Di Gregorio F; Musumeci S; Russo G
    Am J Dis Child; 1982 Dec; 136(12):1099. PubMed ID: 7148769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various immunologic problems of thalassemia major].
    Esposito L; Ferrara M; Lama G
    Pediatria (Napoli); 1977 Sep; 85(3):443-51. PubMed ID: 304206
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered T and B lymphocytes in multitransfused patients of thalassemia major.
    Dua D; Choudhury M; Prakash K
    Indian Pediatr; 1993 Jul; 30(7):893-6. PubMed ID: 8132281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I antibodies in thalassemic patients.
    Nathalang O; Torcharus K; Chuansumrit A; Punyaprasiddhi P; Sriphaisal T; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):801-4. PubMed ID: 10772568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The features of immune status of major beta-thalassemia patients during various periods after splenectomy].
    Kadymova EA
    Georgian Med News; 2009 Sep; (174):39-44. PubMed ID: 19801729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective function of the peripheral blood neutrophils in thalassemia major.
    Giuntoli JM; Estévez ME; Sen L; Peñalver JA
    Am J Pediatr Hematol Oncol; 1984; 6(2):215-7. PubMed ID: 6380328
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune profile alterations in thalassaemic patients.
    Quintiliani L; Mastromonaco A; Giuliani E; Buzzonetti A; Sisti P; Guglielmetti M; Iudicone P; Greca E; Damiano AM; Ciancamerla AM
    Boll Ist Sieroter Milan; 1983; 62(6):524-30. PubMed ID: 6677264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte antibodies in thalassemic patients.
    Sujirachato K; Chiewsilp P; Isarangkura P
    Birth Defects Orig Artic Ser; 1988; 23(5B):283-5. PubMed ID: 3390553
    [No Abstract]   [Full Text] [Related]  

  • 12. Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
    Goicoa MA; Estevez ME; Ballart IJ; Diez RA; Peñalver JA; de Miani SA; Sen L
    Nouv Rev Fr Hematol (1978); 1986; 28(2):75-9. PubMed ID: 3737398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunological profile before and after splenectomy in homozygous beta-thalassemia].
    Esposito L; Ferrara M; Ponte G
    Pediatria (Napoli); 1980 Jun; 88(2):161-9. PubMed ID: 6972519
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of hepatitis-B virus markers in multi-transfused thalassemic patients.
    Mital MK; Vij JC; Talukdar B; Sachdev HP; Saini L
    Indian Pediatr; 1988 Feb; 25(2):161-5. PubMed ID: 3246395
    [No Abstract]   [Full Text] [Related]  

  • 15. Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival.
    Pearson HA; Rink L; Guiliotis DK
    Conn Med; 1994 May; 58(5):259-60. PubMed ID: 8076456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood transplantation for thalassemia.
    Issaragrisil S
    Curr Hematol Rep; 2005 Nov; 4(6):415-6. PubMed ID: 16232375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of splenectomy on lymphocyte populations in thalassemia major].
    Ballart IJ; Díez RA; Estévez ME; Sen L; Goicoa MA; de Miani SA; Peñalver J
    Sangre (Barc); 1985; 30(2):137-45. PubMed ID: 4012516
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of anti-Au antibodies in polytransfused thalassemic patients].
    Moscatelli P; Burlando L; Sciarratta GV
    Pathologica; 1971; 63(925):275-9. PubMed ID: 5155559
    [No Abstract]   [Full Text] [Related]  

  • 19. [Patient compliance in iron-chelating therapy of beta-thalassemia major].
    Di Gregorio F; Romeo MA; Tasca R; Passaniti G
    Minerva Pediatr; 1983 May; 35(10):489-93. PubMed ID: 6877194
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thalassemia and HLA antigens].
    Kolevski P; Mladenovski B; Zisovski N; Ivanovski D; Nedelkovski J
    God Zb Med Fak Skopje; 1979 Jan; 25():289-94. PubMed ID: 262739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.